These mouse studies suggest that additional variations in the Notch signaling pathway genes could be present in some ALGS patients with severe kidney disease in addition to a mutation in JAG1 or NOTCH2. Additional genetic modifiers may also be present in genes involved in unique functions that Notch signaling mediates in the kidney of ALGS patients with severe kidney disease. The gene discussed is JAG1; the disease is kidney disorder.